Soleil Securities Upgrades Varian Medical Systems (VAR) to Buy; Raises FY10-11 Estimates & PT
More News related to VAR
- Wells Fargo Initiates Coverage on Varian Medical Systems (VAR) with a Market Perform
- University College Hospital in London Introduces Treatments Delivering Faster Form of Radiotherapy
- Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair
- Varian Medical (VAR) Discloses New 5M Share Buyback Plan
- Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer
More News related to Upgrades
- Green Mountain (GMCR) Will Likely Win Diedrich Coffee (DDRX) Bidding War - Analyst
- SkyPeople (SPU) Acquires Yingkou Trusty Fruits in $3.3M Transaction
- GE (GE) Said to Restart NBC Universal Acquisition Talks -WSJ
- Diedrich Coffee (DDRX) Comments on Green Mountain Coffee Roasters' (GMCR) Revised Offer
- Peet's (PEET) Issues Statement Following News Diedrich (DDRX) Says Green Mountain (GMCR) Revised Offer is 'Superior'
Soleil Securities upgrades Varian Medical Systems (NYSE: VAR) from Hold to Buy. Price target increased from $35 to $52.
Soleil analyst says, "We're raising our rating on Varian Medical Systems from Hold-to-Buy as final 2010 reimbursement rates for radiation oncology are better-than-expected. Bottom-Line: We see the unexpected reversal of draconian reimbursement cuts helping VAR's business sooner-versus-later...We're raising FY10E sales/EPS to $2,331.9MM (vs. Street $2,304.0MM) and $2.80 (vs. Street $2.72)--we're raising FY11E sales/EPS to $2,448.6MM (vs. Street $2,439.6MM) and $3.00 (vs. Street $2.99)."
To see more analyst ratings on VAR Click Here.
Varian Medical Systems, Inc. provides cancer therapy systems worldwide.
Related Categories
UpgradesStocks Mentioned
+0.05Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
